Louis Sullivan

Louis Sullivan

Directeur/Bestuurslid bij UNITED THERAPEUTICS CORPORATION

Vermogen: 4 M $ op 31-05-2026

92 jaar
Commercial Services
Consumer Services
Health Technology

Profiel

Louis Wade Sullivan is the founder of Medical Education for South African Blacks.
Currently, Dr. Sullivan is Chairman & Chief Executive Officer at The Sullivan Alliance since 2014, Co-Chairman at Henry Schein Cares Foundation, Inc., Independent Director at United Therapeutics Corp.
since 2002, President at Morehouse School of Medicine since 1993, and Trustee at America's Public Television Stations since 2011.
Formerly, Dr. Sullivan was Non-Executive Chairman at ANI Pharmaceuticals, Inc. from 2011 to 2013, Chairman at The National Health Museum, Chairman at Public Broadcasting Atlanta, Chairman-Medical Education at South African Blacks, Inc., Independent Director at Bristol Myers Squibb Co., Director at Cigna Holding Co. from 1993 to 2006, Director at Equifax, Inc., Director at General Motors Corp., Director at Georgia-Pacific LLC, Director at Household International, Inc., Director at 3M Co., Independent Director at Henry Schein, Inc. from 2003 to 2016, Director at Inhibitex LLC, Director at Africare, Inc., Director at Project HOPE-The-People-To-People Health Foundation, Inc., Director at Partnership To End Addiction, Co-Director-Hematology Division at Boston University Medical Center Hospital, Director at The Cigna Group, Independent Director at Emergent BioSolutions, Inc. from 2006 to 2025, Assistant Professor at Seton Hall University in 1965, Member-National Executive Council at Scouting America, Trustee at Little League Baseball, Inc., Secretary at US Department of Health & Human Services from 1989 to 1993, President at Morehouse School of Medicine from 1981 to 1989, and Professor at Boston University School of Medicine in 1975.
Education includes undergraduate degree from Morehouse College in 1954 and doctorate from Boston University School of Medicine in 1958.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
10-04-2026 3.790 ( 0,01% ) 2 M $ 31-05-2026
30-04-2025 139.098 ( 0,27% ) 1 M $ 31-05-2026
16-03-2026 2.777 ( 25,56% ) 218 022 $ 31-05-2026

Actieve functies van Louis Sullivan

BedrijvenFunctieBegin
UNITED THERAPEUTICS CORPORATION Directeur/Bestuurslid 01-01-2002
President 01-01-1993
Voorzitter -
The Sullivan Alliance
Algemeen Directeur -
Directeur/Bestuurslid 10-01-2011

Eerdere bekende functies van Louis Sullivan

BedrijvenFunctieEinde
EMERGENT BIOSOLUTIONS INC. Directeur/Bestuurslid 14-11-2025
HENRY SCHEIN, INC. Directeur/Bestuurslid 01-06-2016
ANI PHARMACEUTICALS, INC. Voorzitter 19-06-2013
Directeur/Bestuurslid 19-09-2007
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Louis Sullivan in detail bekijken

Opleiding van Louis Sullivan

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

30

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit30

Health Technology

Finance

Commercial Services

Consumer Durables

Non-Energy Minerals

Finance

Producer Manufacturing

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Consumer Services

Government

Health Services

Consumer Services

Commercial Services

The National Health Museum

Commercial Services

Commercial Services

Boston University Medical Center Hospital

Consumer Services

Consumer Services

The Sullivan Alliance

Health Services

  1. Beurs
  2. Insiders
  3. Louis Sullivan